Ignite Creation Date:
2025-12-24 @ 12:23 PM
Ignite Modification Date:
2025-12-27 @ 9:08 PM
Study NCT ID:
NCT00711061
Status:
COMPLETED
Last Update Posted:
2009-02-10
First Post:
2008-07-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Cardiovascular Risk in Growth Hormone Deficient Young Adult Males After Completing Growth Hormone Therapy
Sponsor:
Children's Mercy Hospital Kansas City
Organization:
Study Overview
Official Title:
Cardiovascular Risk in Growth Hormone Deficient Young Adult Males After Completing Growth Hormone Therapy.
Status:
COMPLETED
Status Verified Date:
2009-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to compare the cardiovascular risks of growth hormone deficient young adult males who have completed growth hormone therapy to healthy young adult males.
Detailed Description:
Adults with growth hormone deficiency are at risk for cardiovascular disease. What age this begins is not known.
The objectives of this study are to compare the following measurements between growth hormone deficient young males 3-7 years post completion of growth hormone treatment and age related healthy controls:
1. Carotid artery imaging
2. Metabolic and cardiac parameters
3. Body composition measurements
The objectives of this study are to compare the following measurements between growth hormone deficient young males 3-7 years post completion of growth hormone treatment and age related healthy controls:
1. Carotid artery imaging
2. Metabolic and cardiac parameters
3. Body composition measurements
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: